Oral Antibiotics to Prevent Postoperative Urinary Tract Infection
Authors:
- Alexis A. DieterADAlexis A. Dieter
- Cindy L. AmundsenCACindy L. Amundsen
- Autumn L. EdenfieldAEAutumn L. Edenfield
- Amie KawasakiAKAmie Kawasaki
- Pamela J. LevinPLPamela J. Levin
- Anthony G. ViscoAVAnthony G. Visco
- Nazema Y. SiddiquiNSNazema Y. Siddiqui
- 1 January 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 123 (1) , 96-103
Abstract
OBJECTIVE: To evaluate whether nitrofurantoin prophylaxis prevents postoperative urinary tract infection (UTI) in patients receiving transurethral catheterization after pelvic reconstructive surgery. METHODS: In a randomized, double-blind, placebo-controlled trial, participants undergoing pelvic reconstructive surgery were randomized to 100 mg nitrofurantoin or placebo once daily during catheterization if they were: 1) discharged with a transurethral Foley or performing intermittent self-catheterization; or 2) hospitalized overnight with a transurethral Foley. Our primary outcome was treatment for clinically suspected or culture-proven UTI within 3 weeks of surgery. Statistical analysis was performed by χ 2 and logistic regression. Assuming 80% power at a P value of .05, 156 participants were needed to demonstrate a two-thirds reduction in UTI. RESULTS: Of 159 participants, 81 (51%) received nitrofurantoin and 78 (49%) received placebo. There were no significant differences in baseline demographics, intraoperative characteristics, duration and type of catheterization, or postoperative hospitalization, except a lower rate of hysterectomy in the nitrofurantoin group. Nitrofurantoin prophylaxis did not reduce the risk of UTI treatment within 3 weeks of surgery (22% UTI with nitrofurantoin compared with 13% UTI with placebo, relative risk 1.73, 95% confidence interval 0.85–3.52, P =.12). Urinary tract infection treatment was higher in premenopausal women, lower in diabetics, and increased with longer duration of catheterization. In logistic regression adjusting for menopause, diabetes, preoperative postvoid residual volume, creatinine clearance, hysterectomy, and duration of catheterization, there was still no difference in UTI with nitrofurantoin as compared with placebo. CONCLUSION: Prophylaxis with daily nitrofurantoin during catheterization does not reduce the risk of postoperative UTI in patients receiving short-term transurethral catheterization after pelvic reconstructive surgery. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, www.clinicaltrials.gov, NCT01450800. LEVEL OF EVIDENCE: IKeywords
This publication has 27 references indexed in Scilit:
- Day of Surgery Urine Cultures Identify Urogynecologic Patients at Increased Risk for Postoperative Urinary Tract InfectionJournal of Urology, 2013
- A Midurethral Sling to Reduce Incontinence after Vaginal Prolapse RepairNew England Journal of Medicine, 2012
- Incidence and risk factors of postoperative urinary tract infection after uterosacral ligament suspensionInternational Urogynecology Journal, 2012
- Risk factors for urinary tract infection following incontinence surgeryInternational Urogynecology Journal, 2011
- Incidence of Perioperative Urinary Tract Infection After Single-dose Antibiotic Therapy for Midurethal SlingsUrology, 2010
- Symptomatic urinary tract infections after surgery for prolapse and/or incontinenceInternational Urogynecology Journal, 2010
- Types of urethral catheters for management of short‐term voiding problems in hospitalized adults: A short version cochrane reviewNeurourology and Urodynamics, 2008
- Prevalence of Symptomatic Pelvic Floor Disorders in US WomenJAMA, 2008
- Epidemiology of urinary tract infections: incidence, morbidity, and economic costsThe American Journal of Medicine, 2002
- Catheter-associated urinary tract infections: Epidemiology, pathogenesis, and preventionThe American Journal of Medicine, 1991